Type One Diabetes Completed Phase 2 Trials for Insulin glargine (DB00047)

Back to Type One Diabetes

Also known as: Diabetes Mellitus, Juvenile-Onset / T1DM - Type 1 Diabetes Mellitus / Diabetes Type I / Type I Diabetes / Type1 Diabetes / Diabetes Type One / Diabete Type 1 / Type One Diabetes Mellitus / Diabetics Mellitus Type 1 / Type 1 Diabetes / Type 1 Diabetes Mellitus (T1DM) / Insulin-Dependent Diabetes Mellitus 1 / Type1diabetes / Diabetes Mellitus Type I / Type1 Diabetes Mellitus / Type 1 Diabetes (T1D) / Diabetes Mellitus Type 1 / Juvenile Onset Diabetes Mellitus / Diabetes Type 1 / Type 1 Insulin-Dependent Diabetes Mellitus / Type I Diabetes Mellitus / Diabetes Mellitus, Sudden-Onset / Type-1 Diabetes Mellitus / Insulin Dependent Diabetes Mellitus 1 / Type 1 Diabetes Mellitus / Juvenile-Onset Diabetes / Diabetes Mellitus, Insulin-Dependent, 1 / Diabetes mellitus type 1 (disorder) / Diabetes mellitus: [juvenile] or [insulin dependent] / Juvenile diabetes / Insulin dependent diabetic / IDDM / Diabetes mellitus insulin-dependent / Insulin-dependent diabetes mellitus / Diabetes mellitus juvenile onset / Immune-mediated diabetes / Insulin dependent diabetes mellitus / Insulin dependent diabetes mel / IDDM - Insulin-dependent diabetes mellitus / Diabetes mellitus - juvenile / Ketosis-prone diabetes mellitus (disorder) / Ketosis-prone diabetes mellitus

Indication	Status	Phase
DBCOND0076728 (Type One Diabetes)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01194245	Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus	Treatment	Hyaluronidase (human recombinant) (DB06205) Insulin aspart (DB01306) Insulin glargine (DB00047) Insulin glulisine (DB01309) Insulin lispro (DB00046)
NCT00447213	A Study for Patients With Type 1 Diabetes Mellitus	Treatment	Insulin glargine (DB00047) Insulin human (DB00030)
NCT00883558	Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus		Hyaluronidase (human recombinant) (DB06205) Insulin glargine (DB00047) Insulin human (DB00030) Insulin lispro (DB00046)
NCT00612040	Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes	Treatment	Insulin aspart (DB01306) Insulin degludec (DB09564) Insulin glargine (DB00047)
NCT01049412	A Study for Patients With Type 1 Diabetes	Treatment	Insulin glargine (DB00047) Insulin peglispro (DB11567)
NCT01658579	Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime Insulin	Treatment	Insulin glargine (DB00047)